SRPT Sarepta Therapeutics, Inc.
Healthcare$16.80-0.94%ClosedMarket Cap: $1.77B
As of 2026-05-25
Insider Statistics (Q1 2026)
Acquisitions
9
Dispositions
25
Buy/Sell Ratio
0.36
Net Shares
-10,611
Shares Acquired
58,950
Shares Disposed
69,561
Total Bought ($)
$0.00
Total Sold ($)
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Mar 13 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | Sell | 256 | $17.03 | 135,064 |
| Fri Mar 13 | Rothfuss Cristin | officer: EVP, General Counsel | Sell | 974 | $17.03 | 137,544 |
| Fri Mar 13 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | Sell | 948 | $17.03 | 225,323 |
| Fri Mar 13 | Mayo Stephen | director | Sell | 7,239 | $17.02 | 1,765 |
| Fri Mar 13 | Estepan Ian Michael | officer: Chief Operating Officer | Sell | 1,097 | $17.03 | 201,983 |
| Wed Mar 11 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | Sell | 162 | $16.95 | 135,433 |
| Wed Mar 11 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | Sell | 113 | $16.95 | 135,320 |
| Wed Mar 11 | Rothfuss Cristin | officer: EVP, General Counsel | Sell | 484 | $16.95 | 138,864 |
| Wed Mar 11 | Rothfuss Cristin | officer: EVP, General Counsel | Sell | 346 | $16.95 | 138,518 |
| Wed Mar 11 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | Sell | 504 | $16.95 | 227,166 |